Alan L. Rubino has been appointed president and chief executive officer of Emisphere Technologies, Inc. Mr. Rubino was also elected to the board of directors.   Mr. Rubino has more than 30 years of biopharmaceutical industry experience. Most recently, he served as chief executive officer and president of New American Therapeutics, where he and his team led the acquisition, marketing, and ultimate sale of Denavir, a topical treatment for HSV-1 cold sores. Mr. Rubino’s career includes 24 yea...